Literature DB >> 3161734

Recurrence rate after successful coronary angioplasty.

M Kaltenbach, G Kober, D Scherer, C Vallbracht.   

Abstract

Among 356 consecutive patients with successful TCA performed between October 1977 and June 1983 follow-up angiograms were performed in 333 patients (94%). A total of 439 follow-up angiograms at 1-48 (average 5.6) months after successful angioplasty were analysed. Restenosis rate was 12% if defined as remaining widening of less than 20% compared with the situation before angioplasty. It was 16% if defined as loss of at least half of the initial gain in luminal diameter, and 17% if defined as increase from immediate post-TCA-stenosis of much greater than 30% or the loss of at least half of the initial gain in luminal diameter. This value dropped to 15% if the subgroup of 30 patients with second TCA and of 14 patients with dilatation of an aortocoronary bypass stenosis were excluded; in both subgroups recurrence rate was higher (33% and 45%, respectively). The observed restenosis rate is less than 50% of that reported by the PTCA registry of the NHLBI. Several factors can possibly be responsible for the reduction in restenosis rate: selection of patients; technique of TCA; medical treatment during and after TCA; modification of risk factors, compliance of patients; unknown factors. Long-term medical treatment with acetyl salicylic acid, nitrates and calcium blockers in high doses is considered to be most probably responsible for the favourable results.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3161734     DOI: 10.1093/oxfordjournals.eurheartj.a061852

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  15 in total

Review 1.  Restenosis after angioplasty.

Authors:  A H Gershlick; D P de Bono
Journal:  Br Heart J       Date:  1990-12

2.  Application of intraluminal ultrasound imaging to vascular stenting.

Authors:  M J Slepian
Journal:  Int J Card Imaging       Date:  1991

Review 3.  Pharmacological approaches to the prevention of restenosis following angioplasty. The search for the Holy Grail? (Part II).

Authors:  J P Herrman; W R Hermans; J Vos; P W Serruys
Journal:  Drugs       Date:  1993-08       Impact factor: 9.546

4.  Ultrastructural characteristics of cellular reaction after experimentally induced lesions in the arterial vessel.

Authors:  P Gonschior; F Gerheuser; H A Lehr; U Welsch; B Höfling
Journal:  Basic Res Cardiol       Date:  1995 Mar-Apr       Impact factor: 17.165

5.  Pharmacological therapy after coronary angioplasty. Early experience with low molecular weight heparin for prophylaxis of reocclusion.

Authors:  T Schmidt; U Tebbe; J Schrader; S Brune; H Kreuzer
Journal:  Klin Wochenschr       Date:  1990-03-05

6.  Pravastatin reduces restenosis after coronary angioplasty of high grade stenotic lesions: results of SHIPS (SHIga Pravastatin Study).

Authors:  Y Nakamura; O Yamaoka; K Uchida; N Morigami; Y Sugimoto; T Fujita; T Inoue; T Fuchi; M Hachisuka; H Ueshima; H Shimakawa; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1996-09       Impact factor: 3.727

7.  Long-term angiographic follow up, cardiac events, and survival in patients undergoing percutaneous transluminal coronary angioplasty.

Authors:  S M Ernst; T A van der Feltz; E T Bal; L van Bogerijen; E van den Berg; C A Ascoop; H W Plokker
Journal:  Br Heart J       Date:  1987-03

8.  Influence of a variant angina on the results of percutaneous transluminal coronary angioplasty.

Authors:  F Leisch; W Schützenberger; K Kerschner; W Herbinger
Journal:  Br Heart J       Date:  1986-10

9.  Efficacy of a third coronary angioplasty for a second restenosis: short-term results, long-term follow up, and correlates of a third restenosis.

Authors:  K H Tan; N Sulke; N Taub; S Karani; E Sowton
Journal:  Br Heart J       Date:  1995-04

10.  Noradrenaline depletion in patients with coronary artery disease before and after percutaneous transluminal coronary angioplasty with iodine-123 metaiodobenzylguanidine and single-photon emission tomography.

Authors:  C Guertner; H Klepzig; F D Maul; A Hartmann; S Lelbach; A Hellmann; G Hoer
Journal:  Eur J Nucl Med       Date:  1993-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.